FindTrial
Sign In

The key technology of precision pathological diagnosis and molecular classification of glioma

The key technology of precision pathological diagnosis and molecular classification of glioma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047910
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-08-10
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

case series:None

Sponsors

First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 75 Years

Inclusion criteria

Inclusion criteria: More than 2 pathologists jointly read the films and confirmed the diagnosis of glioma.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Copy number variation;Structural variation;—

Countries

China

Contacts

Public ContactYao Xiaohong

First Affiliated Hospital of Army Medical University, PLA

yxh15@hotmail.com+86 15923566825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026